Linc AB (STO:LINC)

Market Cap	4.23B
Revenue (ttm)	1.29B
Net Income (ttm)	1.30B
Shares Out	57.91M
EPS (ttm)	22.48
PE Ratio	3.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,804
Average Volume	76,838
Open	73.60
Previous Close	73.10
Day's Range	72.70 - 73.90
52-Week Range	59.70 - 103.40
Beta	0.90
RSI	38.45
Earnings Date	Jan 24, 2025

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC

Financial Performance

In 2024, Linc AB's revenue was 1.29 billion, an increase of 95.80% compared to the previous year's 659.45 million. Earnings were 1.30 billion, an increase of 110.12%.